Build Your Comparison

Side-by-side financial analysis
PROV logo
PROV
ICE logo
ICE
JPM logo
JPM
CME logo
CME
GS logo
GS
KO logo
KO
Try popular comparisons:

Stock Comparison

PROV vs ICE vs JPM vs CME vs GS vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROV
Provident Financial Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$109M
5Y Perf.+27.6%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$79.60B
5Y Perf.+53.4%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$97.79B
5Y Perf.+65.8%
GS
The Goldman Sachs Group, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$337.53B
5Y Perf.+437.8%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+84.9%

PROV vs ICE vs JPM vs CME vs GS vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROV logoPROV
ICE logoICE
JPM logoJPM
CME logoCME
GS logoGS
KO logoKO
IndustryBanks - RegionalFinancial - Data & Stock ExchangesBanks - DiversifiedFinancial - Data & Stock ExchangesFinancial - Capital MarketsBeverages - Non-Alcoholic
Market Cap$109M$79.60B$896.00B$97.79B$337.53B$355.61B
Revenue (TTM)$60M$12.64B$280.33B$6.76B$125.10B$49.28B
Net Income (TTM)$7M$3.30B$57.05B$4.24B$17.18B$13.70B
Gross Margin67.8%61.9%60.0%86.3%47.5%61.7%
Operating Margin16.2%38.7%25.9%65.6%17.5%29.3%
Forward P/E15.4x17.3x14.4x22.0x17.9x25.3x
Total Debt$213M$20.28B$942.38B$3.76B$609.53B$45.49B
Cash & Equiv.$53M$837M$343.34B$4.42B$164.26B$10.27B

PROV vs ICE vs JPM vs CME vs GS vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROV
ICE
JPM
CME
GS
KO
StockJun 20Jun 26Return
Provident Financial… (PROV)100127.6+27.6%
Intercontinental Ex… (ICE)100153.4+53.4%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
CME Group Inc. (CME)100165.8+65.8%
The Goldman Sachs G… (GS)100537.8+437.8%
The Coca-Cola Compa… (KO)100184.9+84.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROV vs ICE vs JPM vs CME vs GS vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CME leads in 2 of 7 categories (6-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Provident Financial Holdings, Inc. is the stronger pick specifically for capital preservation and lower volatility. ICE, JPM, GS, and KO also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇CME emerged as the overall leader. Track its performance:
PROV
Provident Financial Holdings, Inc.
The Banking Pick

PROV is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 0 yrs, beta 0.21, yield 3.3%
  • Beta 0.21, yield 3.3%, current ratio 0.06x
  • NIM 2.8% vs GS's 0.7%
  • Beta 0.21 vs GS's 1.60, lower leverage
Best for: income & stability and defensive
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.

  • Rev growth 7.5%, EPS growth 20.7%
  • Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
  • 7.5% NII/revenue growth vs GS's -1.4%
Best for: growth exposure and sleep-well-at-night
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is valuation efficiency.

  • PEG 0.81 vs KO's 2.26
  • Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Best for: valuation efficiency
CME
CME Group Inc.
The Banking Pick

CME has the current edge in this matchup, primarily because of its strength in quality and dividends.

  • 62.8% margin vs PROV's 11.0%
  • 4.1% yield, 15-year raise streak, vs KO's 2.5%
Best for: quality and dividends
GS
The Goldman Sachs Group, Inc.
The Banking Pick

GS is the clearest fit if your priority is long-term compounding.

  • 6.7% 10Y total return vs JPM's 465.8%
  • +72.7% vs ICE's -20.4%
Best for: long-term compounding
KO
The Coca-Cola Company
The Niche Pick

KO is the clearest fit if your priority is efficiency.

  • 13.1% ROA vs PROV's 0.5%, ROIC 15.8% vs 1.9%
Best for: efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthICE logoICE7.5% NII/revenue growth vs GS's -1.4%
ValueJPM logoJPMLower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Quality / MarginsCME logoCME62.8% margin vs PROV's 11.0%
Stability / SafetyPROV logoPROVBeta 0.21 vs GS's 1.60, lower leverage
DividendsCME logoCME4.1% yield, 15-year raise streak, vs KO's 2.5%
Momentum (1Y)GS logoGS+72.7% vs ICE's -20.4%
Efficiency (ROA)KO logoKO13.1% ROA vs PROV's 0.5%, ROIC 15.8% vs 1.9%

PROV vs ICE vs JPM vs CME vs GS vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Fintech Stocks Theme

These companies are key players in the Fintech Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
PROVProvident Financial Holdings, Inc.
FY 2025
Debit Card
53.2%$1M
Deposit Account
46.8%$1M
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
GSThe Goldman Sachs Group, Inc.
FY 2025
Global Markets
71.1%$41.5B
Investment Management
28.6%$16.7B
Platform Solutions
0.3%$151M
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

PROV vs ICE vs JPM vs CME vs GS vs KO — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGICE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to PROV's 11.0%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$60M$12.6B$280.3B$6.8B$125.1B$49.3B
EBITDAEarnings before interest/tax$12M$6.5B$81.4B$4.7B$24.0B$15.5B
Net IncomeAfter-tax profit$7M$3.3B$57.0B$4.2B$17.2B$13.7B
Free Cash FlowCash after capex$9M$4.3B$100.9B$4.4B-$47.2B$12.6B
Gross MarginGross profit ÷ Revenue+67.8%+61.9%+60.0%+86.3%+47.5%+61.7%
Operating MarginEBIT ÷ Revenue+16.2%+38.7%+25.9%+65.6%+17.5%+29.3%
Net MarginNet income ÷ Revenue+11.0%+26.1%+20.4%+62.8%+13.7%+27.8%
FCF MarginFCF ÷ Revenue+15.3%+33.9%+36.0%+64.4%-37.7%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+12.1%
EPS Growth (YoY)Latest quarter vs prior year+69.2%+23.1%+16.0%+21.4%+45.8%+18.2%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

JPM leads this category, winning 4 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 41% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs ICE's 2.74x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
Market CapShares × price$109M$79.6B$896.0B$97.8B$337.5B$355.6B
Enterprise ValueMkt cap + debt − cash$269M$99.0B$1.50T$97.1B$782.8B$390.8B
Trailing P/EPrice ÷ TTM EPS18.40x24.36x16.00x24.15x20.71x27.18x
Forward P/EPrice ÷ next-FY EPS est.15.41x17.34x14.40x21.98x17.93x25.27x
PEG RatioP/E ÷ EPS growth rate2.74x0.90x1.76x1.32x2.43x
EV / EBITDAEnterprise value multiple21.77x15.34x18.36x21.56x32.57x26.39x
Price / SalesMarket cap ÷ Revenue1.81x6.30x3.20x15.00x2.70x7.42x
Price / BookPrice ÷ Book value/share0.90x2.77x2.47x3.38x2.70x10.40x
Price / FCFMarket cap ÷ FCF13.38x18.56x8.88x23.32x67.15x
JPM leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 4 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $5 for PROV. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 4.88x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs GS's 5/9, reflecting strong financial health.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity+5.1%+11.6%+15.9%+15.3%+13.6%+41.1%
ROA (TTM)Return on assets+0.5%+2.3%+1.3%+2.2%+1.0%+13.1%
ROICReturn on invested capital+1.9%+7.5%+4.5%+10.2%+2.2%+15.8%
ROCEReturn on capital employed+2.4%+9.5%+8.9%+3.6%+4.0%+17.3%
Piotroski ScoreFundamental quality 0–9695557
Debt / EquityFinancial leverage1.66x0.70x2.60x0.13x4.88x1.33x
Net DebtTotal debt minus cash$160M$19.4B$599.0B-$666M$445.3B$35.2B
Cash & Equiv.Liquid assets$53M$837M$343.3B$4.4B$164.3B$10.3B
Total DebtShort + long-term debt$213M$20.3B$942.4B$3.8B$609.5B$45.5B
Interest CoverageEBIT ÷ Interest expense0.47x6.53x0.74x41.55x0.33x10.70x
KO leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in GS five years ago would be worth $30,053 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, GS leads with a +72.7% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors GS at 48.1% vs ICE's 10.4% — a key indicator of consistent wealth creation.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+8.8%-11.8%-0.5%+3.2%+17.2%+20.3%
1-Year ReturnPast 12 months+14.5%-20.4%+21.8%+3.6%+72.7%+17.2%
3-Year ReturnCumulative with dividends+50.9%+34.6%+138.2%+67.9%+224.8%+47.0%
5-Year ReturnCumulative with dividends+18.2%+30.9%+118.2%+46.2%+200.5%+65.6%
10-Year ReturnCumulative with dividends+25.8%+195.3%+465.8%+262.4%+666.8%+121.1%
CAGR (3Y)Annualised 3-year return+14.7%+10.4%+33.6%+18.9%+48.1%+13.7%
GS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and KO each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than GS's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5000.21x0.35x0.94x-0.28x1.60x-0.20x
52-Week HighHighest price in past year$17.42$189.35$337.25$329.16$1095.89$84.04
52-Week LowLowest price in past year$14.95$136.67$262.71$244.56$609.59$65.35
% of 52W HighCurrent price vs 52-week peak+98.2%+74.2%+95.1%+81.9%+97.0%+98.3%
RSI (14)Momentum oscillator 0–10048.831.959.140.157.360.6
Avg Volume (50D)Average daily shares traded8K3.2M7.0M2.6M1.9M12.7M
Evenly matched — CME and KO each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CME and KO each lead in 1 of 2 comparable metrics.

Analyst consensus: PROV as "Hold", ICE as "Buy", JPM as "Buy", CME as "Hold", GS as "Hold", KO as "Buy". Consensus price targets imply 38.0% upside for ICE (target: $194) vs -8.5% for GS (target: $973). For income investors, CME offers the higher dividend yield at 4.05% vs ICE's 1.38%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …JPM logoJPMJPMorgan Chase & …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHoldHoldBuy
Price TargetConsensus 12-month target$16.00$194.00$339.75$320.80$972.70$86.13
# AnalystsCovering analysts103661365548
Dividend YieldAnnual dividend ÷ price+3.3%+1.4%+1.9%+4.1%+1.6%+2.5%
Dividend StreakConsecutive years of raises01315151456
Dividend / ShareAnnual DPS$0.56$1.93$5.95$10.92$16.62$2.04
Buyback YieldShare repurchases ÷ mkt cap+4.1%+1.7%+3.9%+0.3%+3.7%+0.2%
Evenly matched — CME and KO each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 1 of 6 categories (Income & Cash Flow). JPM leads in 1 (Valuation Metrics). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 1 of 6 categories
Loading custom metrics...

PROV vs ICE vs JPM vs CME vs GS vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PROV or ICE or JPM or CME or GS or KO a better buy right now?

For growth investors, Intercontinental Exchange, Inc.

(ICE) is the stronger pick with 7. 5% revenue growth year-over-year, versus -1. 4% for The Goldman Sachs Group, Inc. (GS). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROV or ICE or JPM or CME or GS or KO?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus The Coca-Cola Company at 27. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — PROV or ICE or JPM or CME or GS or KO?

Over the past 5 years, The Goldman Sachs Group, Inc.

(GS) delivered a total return of +200. 5%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: GS returned +666. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROV or ICE or JPM or CME or GS or KO?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 28β versus The Goldman Sachs Group, Inc. 's 1. 60β — meaning GS is approximately -671% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PROV or ICE or JPM or CME or GS or KO?

By revenue growth (latest reported year), Intercontinental Exchange, Inc.

(ICE) is pulling ahead at 7. 5% versus -1. 4% for The Goldman Sachs Group, Inc. (GS). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 26. 6% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROV or ICE or JPM or CME or GS or KO?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROV or ICE or JPM or CME or GS or KO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 25. 3x for The Coca-Cola Company — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.

08

Which pays a better dividend — PROV or ICE or JPM or CME or GS or KO?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 4% for Intercontinental Exchange, Inc. (ICE).

09

Is PROV or ICE or JPM or CME or GS or KO better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). The Goldman Sachs Group, Inc. (GS) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CME: +262. 4%, GS: +666. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROV and ICE and JPM and CME and GS and KO?

These companies operate in different sectors (PROV (Financial Services) and ICE (Financial Services) and JPM (Financial Services) and CME (Financial Services) and GS (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PROV is a small-cap income-oriented stock; ICE is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; CME is a mid-cap income-oriented stock; GS is a large-cap quality compounder stock; KO is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.